(Q41845098)

English

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach

scientific article published on July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

0 references

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

0 references

ventricular remodeling

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

Thomas Trikalinos

2

object named as

Thomas A Trikalinos

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

James E Udelson

6

object named as

James E Udelson

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Daniel G Kramer

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

David M Kent

3

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

George V Antonopoulos

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Marvin A Konstam

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

0 references

publication date

1 July 2010

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

56

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

392-406

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Quantitative synthesis in systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Surrogate end points in clinical trials: are we being misled?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Early treatment with captopril after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Enalapril for severe congestive heart failure. A double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Controlled trial of enalapril in congestive cardiac failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Usefulness of bucindolol in congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

6 June 2018

Simplified calculation of body-surface area.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

16 June 2018

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Mean body weight, height, and body mass index, United States 1960-2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

The effect of chronic digitalization on pump function in systolic heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Meta-analysis for the evaluation of potential surrogate markers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Nonpharmacologic therapy improves functional and emotional status in congestive heart failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4523221

18 August 2018

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Clinical, Hemodynamic, Angiographic, and Neurohumoral Responses to Vasodilation with Felodipine in Patients with Chronic Congestive Heart Failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design of phase II trials in congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulationin Cardiomyopat

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of congestive heart failure and predictors of mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year clinical and echocardiographic follow-up of patients with congestive cardiomyopathy treated with captopril compared to placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the captopril and thrombolysis study (CATS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic vasodilator therapy with flosequinan in congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enalapril on clinical status, biochemistry, exercise performance and haemodynamics in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ventricular remodeling in heart failure: a credible surrogate endpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surrogate end points in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20650361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JACC.2010.05.011

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

release_rq2rpaybdfei5i2nokunwgmzvu

1 reference

https://api.fatcat.wiki/v0/release/rq2rpaybdfei5i2nokunwgmzvu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41845098&oldid=2098341808"